Cardiovascular health, heart failure, atherosclerosis, and cardiac research
419 artigos
A JAMA review synthesizes evidence showing CRT significantly reduces mortality and hospitalizations in heart failure patients with electrical dyssynchrony.
A Harvard-affiliated clinician challenges assumptions about when defibrillation is truly advised in cardiac emergencies.
A 330-patient multicenter RCT tests whether thymosin α1 can curb immune dysregulation and organ dysfunction after acute type A aortic dissection repair.
Major cardiology societies overhaul training requirements for cardiac electrophysiology fellows, reflecting a decade of advances in arrhythmia care.
A 160-patient RCT shows LBBP dramatically reduces pacing-induced cardiomyopathy and preserves heart function over 3 years.
A 965-patient RCT shows omitting defibrillation testing during subcutaneous ICD implantation is non-inferior to routine testing when device position is scored by chest X-ray.
A protein linked to cardiovascular protection predicts mitral valve deterioration and heart failure risk after STEMI, opening a new prognostic window.
New evidence suggests oral semaglutide sustains long-term improvements in key CVD risk factors, expanding its role beyond diabetes management.
A landmark AHA statement challenges decades of blanket activity restrictions for children with cardiomyopathy, offering new risk-stratified guidance.
Isoquercitrin reshapes gut bacteria and tryptophan metabolism to reduce arterial plaque, pointing to a novel gut-heart therapeutic pathway.
A sirtuin enzyme prevents heart scarring by keeping cardiac fibroblasts from switching to a pro-fibrotic metabolic state.
A landmark review maps how computational heart models can decode diabetic cardiomyopathy and predict responses to SGLT2i and GLP-1 drugs.
